Table 5.
Total (n=) | Indication for HPEa (n=) | No indication for HPEa (n=) | |||
Histopathological diagnosis | Normal gallbladder | n (% of ‘Total’) | n | n | |
Acute inflammation | n (% of ‘Total’) | n | n | ||
Chronic inflammation and reactive changes | n (% of ‘Total’) | n | n | ||
Gallbladder neoplasms | Adenoma | n (% of ‘Total’) | n | n | |
Biliary intraepithelial neoplasm | n (% of ‘Total’) | n | n | ||
Carcinoma | n (% of ‘Total’) | n | n | ||
Other malignant neoplasms | n (% of ‘Total’) | nb | nc | ||
Non-neoplastic aberrant findings | Cholesterol polyp | n (% of ‘Total’) | n | n | |
Inflammatory/hyperplastic polyp | n (% of ‘Total’) | n | n | ||
Adenomyomatosis | n (% of ‘Total’) | n | n | ||
Other | n (% of ‘Total’) | n | n |
a. According to the operating surgeon or surgical resident.
b. Details on histology.
c. Details on histology.
HPE, histopathological examination.